During the panel discussion in the Sixth International Childhood Acute Lymphoblastic Leukemia (ALL) meeting of the Ponte di Legno Working Group, held in San Diego in December 2003, it was apparent that recent improvements in treatment have further paradoxically widened the gap of inequality between children living in resource-rich countries and those in low-income countries. The representatives from 15 leading study groups and institutions decided to issue a statement [1. ] to lobby international and national agencies to provide the necessary drugs at affordable cost throughout the world for children with ALL or other highly curable cancer.
We wish to draw a wider readership and support by also publishing this statement in your journal